MedWatch

Drugs that fight diabetes and obesity may treat Covid-19, Novo Nordisk says

Novo Nordisk is exploring whether a new class of medicines that helps people lose weight and control diabetes also has potential in fighting Covid-19.

Novo chief scientific officer Mads Krogsgaard Thomsen. | Foto: Jacob Ehrbahn/Politiken

Research shows people afflicted by obesity and diabetes often fare worse in trying to overcome sars-cov-2.

Now initial analysis of electronic medical records shows that GLP-1 drugs, which help patients keep blood sugar levels in check, could be a "very meaningful therapy" in battling the illness, Novo chief scientific officer Mads Krogsgaard Thomsen said in an interview.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Trial banner

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier